Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 314

The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.

National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016

Open access
Chew, Derek P., Scott, Ian A., Cullen, Louise, French, John K., Briffa, Tom G., Tideman, Philip A., Woodruffe, Stephen, Kerr, Alistair, Branagan, Maree, Aylward, Philip E.G.·2016·Heart, Lung and Circulation

Abstract

These clinical guidelines have been developed to assist in the management of patients presenting with chest pain suspected to be due to an acute coronary syndrome (ACS) and those with confirmed ACS. These guidelines should be read in conjunction with the ACS Clinical Care Standards developed by the Australian Commission for Safety and Quality in Health Care (ACSQHC) [[1]Australian Commission on Safety and Quality in Health Care. Acute Coronary Syndromes Clinical Care Standard. 2014. Available at: http://www.safetyandquality.gov.au/our-work/clinical-care-standards/acute-coronary-syndromes-clinical-care-standard/. Accessed 30/3/16Google Scholar] and the Australian acute coronary syndromes capability framework developed by the Heart Foundation [[2]National Heart Foundation of Australia. Australian acute coronary syndromes capability framework. 2015. Available at: https://heartfoundation.org.au/for-professionals/clinical-information/acute-coronary-syndromes. Accessed 30/3/16.Google Scholar]. Additional guidance around the timing and use of therapies is detailed in the accompanying practice advice. Tabled 1RecommendationGRADE strength of recommendationNHMRC Level of Evidence (LOE)Initial assessment of chest painIt is recommended that a patient with acute chest pain or other symptoms suggestive of an ACS receives a 12-lead ECG and this ECG is assessed for signs of myocardial ischaemia by an ECG-experienced clinician within 10 minutes of first acute clinical contact.StrongIIICA patient presenting with acute chest pain or other symptoms suggestive of an ACS should receive care guided by an evidence-based Suspected ACS Assessment Protocol (Suspected ACS-AP) that includes formal risk stratification.StrongIAUsing serial sampling, cardiac-specific troponin levels should be measured at hospital presentation and at clearly defined periods after presentation using a validated Suspected ACS-AP in patients with symptoms of possible ACS.StrongIANon-invasive objective testing is recommended in intermediate-risk patients, as defined by a validated Suspected ACS-AP, with normal serial troponin and ECG testing and who remain symptom-free.WeakIAPatients in whom no further objective testing for coronary artery disease (CAD) is recommended are those at low risk, as defined by a validated Suspected ACS-AP: age <40 years, symptoms atypical for angina, in the absence of known CAD, with normal troponin and ECG testing, and who remain symptom-free.WeakIII-3CDiagnostic considerations and risk stratification ofThe routine use of validated risk stratification tools for ischaemic and bleeding events (e.g. GRACE score for ischaemic risk or CRUSADE score for bleeding risk) may assist in patient-centric clinical decision-making in regards to ACS care.WeakIIIBAcute reperfusion and invasive management strategies in ACSFor patients with ST elevation myocardial infarction (STEMI) presenting within 12 hours of symptom onset, and in the absence of advanced age, frailty and comorbidities that influence the individual's overall survival, emergency reperfusion therapy with either primary percutaneous coronary intervention (PCI) or fibrinolytic therapy is recommended.StrongIAPrimary PCI is preferred for reperfusion therapy in patients with STEMI if it can be performed within 90 minutes of first medical contact; otherwise fibrinolytic therapy is preferred for those without contra-indications.StrongIAAmong patients treated with fibrinolytic therapy who are not in a PCI-capable hospital, early or immediate transfer to a PCI-capable hospital for angiography, and PCI if indicated, within 24 hours is recommended.WeakIIAAmong patients treated with fibrinolytic therapy, for those with ≤50% ST recovery at 60–90 minutes, and/or with haemodynamic instability, immediate transfer for angiography with a view to rescue angioplasty is recommended.StrongIBAmong high- and very high-risk patients with non-ST elevation acute coronary syndromes (NSTEACS) (except Type 2 MI), a strategy of angiography with coronary revascularisation (PCI or coronary artery bypass grafts) where appropriate is recommended.StrongIAPatients with NSTEACS who have no recurrent symptoms and no risk criteria are considered at low risk of ischaemic events, and can be managed with a selective invasive strategy guided by provocative testing for inducible ischaemia.StrongIATiming of invasive management for NSTEACSVery high-risk patients: Among patients with NSTEACS with very high-risk criteria (ongoing ischaemia, haemodynamic compromise, arrhythmias, mechanical complications of MI, acute heart failure, recurrent dynamic or widespread ST-segment and/or T-wave changes on ECG), an immediate invasive strategy is recommended (i.e. within 2 hours of admission).StrongIICHigh-risk patients: In the absence of very high-risk criteria, for patients with NSTEACS with high-risk criteria (GRACE score >140, dynamic ST-segment and/or T-wave changes on ECG, or rise and/or fall in troponin compatible with MI) an early inv

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.hlc.2016.06.789

Cites

190 of 190 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 190 references

Cited by

See all 314

Metadata

Authors
Chew, D. P., Scott, I. A., Cullen, L., French, J. K., Briffa, T. G., Tideman, P. A., Woodruffe, S., Kerr, A., Branagan, M., & Aylward, P. E. G.
Venue
Heart, Lung and Circulation
Publisher
Elsevier BV
Published
2016-09
Volume
25
Issue
9
Pages
895-951
ISSN
1443-9506 (ISSN-L)
OpenAlex
W2460492626
Cited by
314
References
190
FWCI
21.91
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016. https://app.cochat.ai/papers/10.1016/j.hlc.2016.06.789
The paper
Chew, D. P., Scott, I. A., Cullen, L., French, J. K., Briffa, T. G., Tideman, P. A., Woodruffe, S., Kerr, A., Branagan, M., & Aylward, P. E. G. (2016). National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016. Heart, Lung and Circulation. https://doi.org/10.1016/j.hlc.2016.06.789

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.